Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.023 | 0.7 |
mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.7 |
mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.7 |